Chemoinformatic expedition of the chemical space of fungal products.

AIM Fungi are valuable resources for bioactive secondary metabolites. However, the chemical space of fungal secondary metabolites has been studied only on a limited basis. Herein, we report a comprehensive chemoinformatic analysis of a unique set of 207 fungal metabolites isolated and characterized in a USA National Cancer Institute funded drug discovery project. RESULTS Comparison of the molecular complexity of the 207 fungal metabolites with approved anticancer and nonanticancer drugs, compounds in clinical studies, general screening compounds and molecules Generally Recognized as Safe revealed that fungal metabolites have high degree of complexity. Molecular fingerprints showed that fungal metabolites are as structurally diverse as other natural products and have, in general, drug-like physicochemical properties. CONCLUSION Fungal products represent promising candidates to expand the medicinally relevant chemical space. This work is a significant expansion of an analysis reported years ago for a smaller set of compounds (less than half of the ones included in the present work) from filamentous fungi using different structural properties.

[1]  Thomas Böttcher,et al.  An Additive Definition of Molecular Complexity , 2016, J. Chem. Inf. Model..

[2]  M. Grever,et al.  Sorbicillinoid Analogues with Cytotoxic and Selective Anti-Aspergillus Activities from Scytalidium album , 2014, The Journal of Antibiotics.

[3]  José L. Medina-Franco,et al.  Chemoinformatic Analysis of GRAS (Generally Recognized as Safe) Flavor Chemicals and Natural Products , 2012, PloS one.

[4]  M. Jordan,et al.  Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase , 2008, Molecular Cancer Therapeutics.

[5]  Karina Martinez-Mayorga,et al.  Balancing novelty with confined chemical space in modern drug discovery , 2014, Expert opinion on drug discovery.

[6]  C. Pearce,et al.  Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of the Bionectriaceae , 2012, The Journal of Antibiotics.

[7]  Tudor I. Oprea,et al.  Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry , 2005, J. Chem. Inf. Model..

[8]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[9]  H. Raja,et al.  Peptaibols, tetramic acid derivatives, isocoumarins, and sesquiterpenes from a Bionectria sp. (MSX 47401). , 2013, Journal of natural products.

[10]  H. Raja,et al.  Biosynthetically Distinct Cytotoxic Polyketides from Setophoma terrestris. , 2015, European journal of organic chemistry.

[11]  Thomas Sander,et al.  DataWarrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis , 2015, J. Chem. Inf. Model..

[12]  A. Kaur,et al.  New diketopiperazine dimer from a filamentous fungal isolate of Aspergillus sydowii , 2015, Magnetic resonance in chemistry : MRC.

[13]  H. Raja,et al.  Waol A, trans-dihydrowaol A, and cis-dihydrowaol A: polyketide-derived γ-lactones from a Volutella species. , 2013, Tetrahedron letters.

[14]  C. Pearce,et al.  Cyclodepsipeptides, sesquiterpenoids, and other cytotoxic metabolites from the filamentous fungus Trichothecium sp. (MSX 51320). , 2011, Journal of natural products.

[15]  David S. Wishart,et al.  DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..

[16]  P. Jaccard,et al.  Etude comparative de la distribution florale dans une portion des Alpes et des Jura , 1901 .

[17]  Brandie M. Ehrmann,et al.  Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and anthelmintic activities , 2012, Journal of peptide science : an official publication of the European Peptide Society.

[18]  James C Griffiths,et al.  The importance of GRAS to the functional food and nutraceutical industries. , 2006, Toxicology.

[19]  L. Mueller-Kuhrt,et al.  Putting nature back into drug discovery , 2003, Nature Biotechnology.

[20]  J. Medina-Franco,et al.  Discovery and Development of Lead Compounds from Natural Sources Using Computational Approaches , 2015 .

[21]  S. Matthew,et al.  Cytotoxic Xanthone-Anthraquinone Heterodimers from an Unidentified Fungus of the Order Hypocreales (MSX 17022) , 2011, The Journal of Antibiotics.

[22]  J. Medina-Franco,et al.  Expanding the medicinally relevant chemical space with compound libraries. , 2012, Drug discovery today.

[23]  Brandie M. Ehrmann,et al.  Thielavin B methyl ester: a cytotoxic benzoate trimer from an unidentified fungus (MSX 55526) from the Order Sordariales. , 2011, Tetrahedron letters.

[24]  Stefan Günther,et al.  The Purchasable Chemical Space: A Detailed Picture , 2015, J. Chem. Inf. Model..

[25]  A. Kinghorn,et al.  Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents. , 2012, ACS medicinal chemistry letters.

[26]  Rajarshi Guha,et al.  Chemoinformatic Analysis of Combinatorial Libraries, Drugs, Natural Products, and Molecular Libraries Small Molecule Repository , 2009, J. Chem. Inf. Model..

[27]  Miklos Feher,et al.  Property Distributions: Differences Between Drugs, Natural Products, and Molecules from Combinatorial Chemistry. , 2003 .

[28]  S. Matthew,et al.  Resorcylic acid lactones with cytotoxic and NF-κB inhibitory activities and their structure-activity relationships. , 2011, Journal of natural products.

[29]  Nicholas H Oberlies,et al.  Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite. , 2011, Journal of natural products.

[30]  J. Medina-Franco,et al.  Epigenetic relevant chemical space: a chemoinformatic characterization of inhibitors of DNA methyltransferases , 2015 .

[31]  Yang Song,et al.  Therapeutic target database update 2012: a resource for facilitating target-oriented drug discovery , 2011, Nucleic Acids Res..

[32]  David J Newman,et al.  Cheminformatic comparison of approved drugs from natural product versus synthetic origins. , 2015, Bioorganic & medicinal chemistry letters.

[33]  C. Pearce,et al.  Dereplication of Macrocyclic Trichothecenes from Extracts of Filamentous Fungi through UV and NMR Profiles , 2010, The Journal of Antibiotics.

[34]  C. Pearce,et al.  Revisiting the enniatins: a review of their isolation, biosynthesis, structure determination and biological activities , 2012, The Journal of Antibiotics.

[35]  José L. Medina-Franco,et al.  MOLECULAR SIMILARITY ANALYSIS , 2013 .

[36]  José L Medina-Franco,et al.  Molecular Scaffold Analysis of Natural Products Databases in the Public Domain , 2012, Chemical biology & drug design.

[37]  Christel A. S. Bergström,et al.  In silico predictions of drug solubility and permeability: two rate-limiting barriers to oral drug absorption. , 2005, Basic & clinical pharmacology & toxicology.

[38]  C. Day,et al.  Benzoquinones and terphenyl compounds as phosphodiesterase-4B inhibitors from a fungus of the order Chaetothyriales (MSX 47445). , 2013, Journal of natural products.

[39]  Nicholas H Oberlies,et al.  High-resolution MS, MS/MS, and UV database of fungal secondary metabolites as a dereplication protocol for bioactive natural products. , 2013, Journal of natural products.

[40]  C. Pearce,et al.  Obionin B: An o-pyranonaphthoquinone decaketide from an unidentified fungus (MSX 63619) from the Order Pleosporales. , 2011, Tetrahedron letters.

[41]  Stuart L. Schreiber,et al.  Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles , 2010, Proceedings of the National Academy of Sciences.

[42]  Kolkata,et al.  Evidence-Based Validation of Herbal Medicine , 2016 .

[43]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[44]  A. Ganesan.  The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.

[45]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.